✦ LIBER ✦

Risk in CNS drug discovery: focus on treatment of Alzheimer's Disease

✍ Scribed by JFred Pritchard

Book ID: 115007740
Publisher: BioMed Central
Year: 2008
Tongue: English
Weight: 201 KB
Volume: 9
Category: Article
ISSN: 1471-2202
DOI: 10.1186/1471-2202-9-s3-s1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Polypharmacology in Drug Discovery (Pete

Polypharmacology in Drug Discovery (Peters/Polypharmacology) || Multitargeted Drugs for Treatment of Alzheimer's Disease

✍ Peters, Jens-Uwe 📂 Article 📅 2012 🏛 John Wiley & Sons, Inc. 🌐 English ⚖ 227 KB

Covers The Two-sided Nature Of Polypharmacology--its Contribution To Adverse Drug Reactions And Its Benefit In Certain Therapeutic Drug Classes. Addresses The Important Topic Of Polypharmacology In Drug Discovery, A Subject That Has Not Been Thoroughly Covered Outside Of Scattered Journal Articles O

Application of molecular topology in Alz

Application of molecular topology in Alzheimer's disease drug discovery

✍ Pasinetti, Giulio; Land, David; Galvez, Jorge; Wang, Jun 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 51 KB

Tau-directed drug discovery for Alzheime

Tau-directed drug discovery for Alzheimer's disease and related tauopathies: A focus on tau assembly inhibitors

✍ Kurt R. Brunden; Carlo Ballatore; Alex Crowe; Amos B. Smith; III; Virginia M.-Y. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 590 KB

CNS Targets for multi-functional drugs i

CNS Targets for multi-functional drugs in the treatment of Alzheimer’s and Parkinson’s diseases

✍ M. B. H. Youdim; J. J. Buccafusco 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 350 KB

Potential use of CNS directed drug deliv

Potential use of CNS directed drug delivery systems in Alzheimer's disease

📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 144 KB

Advances in the drug treatment of Alzhei

Advances in the drug treatment of Alzheimer's Disease

✍ B. E. Leonard 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 133 KB 👁 2 views

There are two main approaches to the treatment of Alzheimer's disease. The ®rst approach is to prevent the neurodegenerative changes that ultimately cause irreversible damage to the brain. As the excessive formation of betaamyloid protein appears to play a primary role in the neurodegenerative proce